Dividends & Buybacks ·
Virax Biolabs Group Limited shareholders approved a share consolidation of ordinary shares on June 12, 2026…
VRAXVirax Biolabs Group Ltd
Virax Biolabs Group Limited shareholders approved a share consolidation of ordinary shares on June 12, 2026, consolidating every 10 to 30 outstanding shares into one new ordinary share. The company also approved an amended and restated memorandum and articles of association to reflect the revised authorized share capital. Virax Biolabs Group Limited is a biotechnology company that develops and manufactures products for infectious disease control and infectious disease diagnostics.